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 ABSTRACT 20 
In this study we investigated the viscoelastic and mechanical behaviour of polyvinyl 21 
alcohol (PVA) films formulated along with carrageenan, plasticizing agents (polyethylene 22 
glycol and glycerol), and when loaded with nanoparticles (NP) as a model for potential 23 
applications as microbicides. The storage modulus, loss modulus and glass transition 24 
temperature were determined using a dynamic mechanical analyzer (DMA). Films 25 
fabricated from 2% and 5% PVA containing 3mg or 5mg of fluorescently-labeled NPs were 26 
evaluated. The storage modulus and loss modulus values of blank films were shown to be 27 
higher than the NP-loaded films. Glass transition temperature determined using the storage 28 
modulus was between 40-50°C and 35-40°C using the loss modulus. The tensile properties 29 
evaluated showed that 2% PVA films were more elastic but less resistant to breaking 30 
compared to 5% PVA films (2% films break around 1N load and 5% films break around 7N 31 
load). To our knowledge, this is the first study to evaluate the influence of NP and film 32 
composition on the physico-mechanical properties of polymeric films for vaginal drug 33 
delivery. 34 
 35 
 36 
 37 
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1. INTRODUCTION 41 
 3 
Polymeric films are increasingly gaining attention as drug delivery systems due to their 42 
ability to provide rapid drug release and bio-adhesive properties that may increase the 43 
retention time at the target tissue. Film-formulated products offer user compliance as well 44 
as ease of application. Recently, a number of researchers have focused on the development 45 
of polymeric vaginal films as contraceptives and microbicide formulations1-5.  The potential 46 
of vaginal films for contraceptive or microbicide applications is mainly due to their ability 47 
to overcome several challenges related to acceptability, compliance, and efficacy in 48 
comparison to gel-based formulations5-7. For example, gels are messy and may leak 49 
resulting in reduced drug concentrations. Despite films demonstrating to be a promising 50 
drug delivery platform, the type of bioactive being delivered will affect the mechanical, 51 
chemical and physical properties of the film, which in turn will also alter drug release 52 
rates7. 53 
Polyvinyl alcohol (PVA) is a polymer that is widely used in a variety of applications due to 54 
its biodegradability and its ease in preparation8. PVA is a water-soluble and crystalline 55 
polymer. This material can form films that are biocompatible with good mechanical 56 
properties allowing its use in various industrial and medical applications. It has been used 57 
in pharmaceutics as a drug delivery system due to its high water solubility and rapid 58 
disintegration rate3, 9. Polymeric films can be designed to be highly resistant to repeated 59 
flexure or creasing10. Some of the film properties such as tensile strength, and permeability 60 
to gases or water vapour may be important features to consider when developing a drug 61 
delivery system11. Studies have shown that thin polymeric films tend to degrade in the 62 
presence of destabilizing forces such as heat and mechanical stress at the film’s interface10, 63 
12. Quantitatively, such instabilities affect the thermal and mechanical characteristics of the 64 
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film10, 12.  Depending on the plasticizer, excipients, or drug loaded into the films, it can 65 
exhibit different physico-chemical behaviours.  66 
Numerous studies are using polymeric film formulations to deliver nanoparticles (NPs)13, 14. 67 
The nanocarrier is used to protect the active compound from its external environment, can 68 
assist in active targeted delivery, and can provide controlled, sustained drug release15. They 69 
have been used to address the concerns of physicochemical instability of drugs, low cellular 70 
uptake and the need for multiple dosing16. For example, different PVA films with different 71 
thickness have been formulated to deliver varying concentrations of poly(D,L-lactic-co-72 
glycolic acid)-poly(ethylene glycol) NPs containing siRNA as a therapy for preventing HIV 73 
infection within the female genital tract4.  74 
Hence, the objective of this study was to experimentally determine the influence of NP 75 
content and film composition on the physico-mechanical properties of NP-loaded PVA 76 
films subjected to varying temperature ranges. 77 
 78 
2. MATERIALS AND METHODS 79 
Degradex® fluorescent PLGA NPs were purchased from phosphorex (Hopkinton, 80 
Massachusetts, USA). PVA (98-99% hydrolyzed; MW 31,000-50,000) and λ-carrageenan 81 
was purchased from American Custom Chemicals Corp (San Diego, CA, USA). Phosphate-82 
buffered saline (PBS; pH 7.4) was purchased from Lonza (Allendale, NJ, USA).  Double 83 
distilled water (ddH2O) was purified using Millipore Simplicity System, which was used 84 
for all the experiments. 85 
2.1. Preparation of nanoparticle-loaded film  86 
 5 
PVA films were prepared by a solvent casting method as previously described4. Briefly, 87 
PVA and carrageenan were dissolved overnight in distilled water at 80°C. The PVA 88 
solution was allowed to cool down to room temperature and diluted to either 5% or 2% 89 
solution (w/v). 240 µL of glycerol and 80 µL of PEG400 were mixed in 8 mL of the 90 
solution and allowed to stir for 1 h. Commercially available fluorescent NPs (200 nm) were 91 
added and mixed for an additional 1 h to prepare 5% film containing NPs with a w/w ratio 92 
of 1:88 [NP:(PVA+carrageenan)] for 5 mg NPs loading and 1:147 for 3 mg NP loading. 93 
For the 2% film, a w/w ratio of 1:40 and 1:67 were used for 5mg and 2 mg NP loading, 94 
respectively.  The mixture was poured into a TeflonTM dish (30 cm2) and placed in the oven 95 
at 40°C overnight to evaporate the solvent and to form the film. 96 
2.2. Dynamic mechanical analysis 97 
Dynamic mechanical analysis (DMA) of the films was performed using a DMA Q800 (TA 98 
Instruments, New Castle, USA) in tensile mode. Film samples (2% and 5% PVA blank 99 
films or NP-loaded films) were cut into sizes between 5-6.5 mm in width, 20-30 mm in 100 
length, and 0.5-0.7 mm in thickness in order to conform to the dimensional limits required 101 
for the tensile film clamp test fixture. The average thickness for each film sample was 102 
based on three separate measurements, taken at the two ends and in the middle. The DMA 103 
test procedure was as follows: after mounting the film sample on the DMA tension film 104 
clamp, the furnace was sealed and the mechanical properties were measured from 25 ºC to 105 
80 ºC at a ramp rate of 3 ºC per min under a preload of 0.5 N. Measurements were 106 
performed at a constant frequency of 1 Hz and strain amplitude of 10 μm. The glass 107 
transition temperature, the real (storage) modulus E´, and imaginary (loss) modulus E´´ was 108 
determined using the thermal analysis software (TA Instrument Universal Analysis 2000) 109 
included with the DMA apparatus. The software automatically detects signal change on the 110 
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analysis curve. The inflection point on the curve of the modulus can be considered the glass 111 
transition temperature and is determined using the tangent of the onset point and the end 112 
point17, 18.  Three independent runs were performed for each film formulation throughout 113 
this paper.  114 
2.3. In vitro drug release 115 
PVA film samples (2% and 5% fluorescent NP-loaded films cut to around 20 mg) were 116 
suspended in 1 mL release medium (PBS pH 7.4). The fluorescent NP-loaded film 117 
suspension was transferred to an orbital shaker maintained at 37 ºC at a speed of 100 rpm 118 
(VWR, Edmonton, Canada). 200 µL aliquot of samples were periodically removed for 119 
analysis and were replenished with equal volume of fresh medium. The fluorescent NP 120 
concentration in the samples was analyzed on a microplate reader (BioTek Synergy) with 121 
an excitation wavelength of 530 nm and an emission wavelength of 590 nm. Samples were 122 
taken and analyzed in triplicate for each time point. Films disintegration have been 123 
evaluated also by immersing 50 mg of each film in 3 ml of ddH2O in 20 ml vial and place 124 
in the orbital shaker at 37 ºC at a speed of 100 rpm. Visual inspection is used to record the 125 
disintegration rate.   126 
2.4. Determination of mechanical properties 127 
Mechanical analysis was performed on an Instron tensile machine model 5943 with a 128 
crosshead speed of 100 mm/min and a force of 1 kN (load cell) at room temperature. All 129 
the film samples were cut into rectangular shapes with a length of 30±0.3 mm, a width of 130 
6.80±0.7 mm, and a thickness of 0.07 mm for the 2% film and a thickness of 0.16 mm for 131 
the 5% film.  132 
2.5. Scanning electron microscopy 133 
 7 
Scanning electron microscopy (SEM) studies were carried out using a Quanta 650 FEG 134 
equipped X-ray microanalysis with low-vacuum capabilities at a voltage of 10 keV. Film 135 
samples were cut into small pieces and attached to slab surfaces with double-sided adhesive 136 
tape. 137 
Statistical analysis 138 
Data are presented as mean ± standard deviation (SD). The n-value refers to number of 139 
replicates performed for each study. One-way ANOVA was performed on all results, with 140 
P<0.05 considered to be significant. 141 
 142 
3. RESULTS  143 
The storage and loss modulus of various 2% and 5% PVA film formulations were 144 
determined (Fig 1). Based on the results, the storage modulus for both 2% and 5% blank 145 
films were slightly higher than their counterpart films loaded with NP. The storage 146 
modulus of 2% blank film varied between 22.90±5.23 MPa to 13.87±2.91 for a temperature 147 
ramp from 30°C to 60°C and 143.24±14.18 to 82.63±5.43 MPa for 5% blank film at the 148 
same temperature ramp. Furthermore, the storage modulus for films containing 3 mg of NP 149 
was also higher than the ones containing 5 mg of NP. PVA films containing 3 mg and 5 mg 150 
vary between 15.67±2.08 to 10.07±1.35 MPa and 12.72±5.29 to 8.15±3.70 MPa, 151 
respectively. The storage modulus decreased gradually as the temperature increased. The 152 
mean storage and loss modulus are presented in Fig 2A and 2B, respectively. The sharpest 153 
slope of the storage modulus was used to determine the glass transition temperature where 154 
the film began its transition from a glassy state to a more rubbery state.  The mean glass 155 
transition temperatures for each film as determined using the storage modulus is presented 156 
 8 
in Fig 2A. As can be seen in Table 1, 2% PVA films loaded with either 3 mg (53.25±2.86 157 
°C) or 5 mg (54.10±7.63°C) NP exhibited higher mean glass transition temperatures 158 
compared to 5% PVA films with 3 mg (40.05±2.09°C) or 5 mg (42.07±2.21°C) NP, 159 
respectively (Table 1), when using the storage modulus for determination. In contrast, no 160 
significant differences were observed in any of the film groups when determining glass 161 
transition temperature using the loss modulus (Table 1B).    162 
 Disintegration studies were performed on blank PVA films and films loaded with 3 163 
or 5 mg of NP. Around 50 mg of each film was immersed in 3 mL of PBS buffer and 164 
placed in an incubator shaker at 37oC and 100 rpm (Table 1). 2% PVA films with 3 or 5 mg 165 
loading disintegrated within 3 hr making the medium cloudy. The 5% PVA films 166 
containing 3 or 5 mg loading partially disintegrated with no changes to the transparency of 167 
the medium.  168 
       In vitro release studies were performed on different film preparations. The amount of 169 
fluorescent NPs released was evaluated using a micro plate reader (Fig 3). Fig 3 represents 170 
the release obtained from 2% PVA films loaded with 3 mg or 5 mg of NPs and 5% films 171 
loaded with 3 mg or 5 mg. 2% films demonstrated a release of 18.92±5.6 µg (8.7±0.7 %) 172 
for 5 mg NP loading and 11.48±1.5 µg (9.8±0.5 %) for 3 mg NP loading after 4 hours 173 
followed by a slow and negligible release up to 24 hours. For 5% film, there a slow release 174 
of NPs up to 24 hours with 6.8±0.8 µg (3.25±0.39 %) for 5mg loading and 4.13±0.36 µg 175 
(3.15±0.27 %) for 3mg loading.  176 
           Tensile properties such as Young’s modulus, maximum load at break, tensile strain 177 
at maximum load and tenacity (used to measure the overall strength) of the film at 178 
maximum load has been calculated from stress-strain curves (Table 3). 2% blank films have 179 
a tensile strain at maximum load of 0.162 mm/mm, and 0.151 mm/mm for films containing 180 
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3 mg NP loading and 0.134 mm/mm for films containing 5 mg NP loading. The 5% blank 181 
films demonstrated to have lower tensile strain and started to break at 0.037 and 0.043 182 
mm/mm for the 3 mg and 5 mg NP loading, respectively. 2 % PVA films present more 183 
elasticity but start breaking at lower load, around 1N compared to 5% PVA film, which 184 
started to break around 7N. The 5% PVA film is less elastic, and broke at only 1 mm of the 185 
crosshead displacement distance compared to the 2% film which broke after 4 mm of 186 
extension. 187 
 The surface morphology of each film was visualized by SEM. The 2% blank film 188 
appeared to have a more porous structure, but became less obvious once loaded with 3mg 189 
or 5 mg NP. In contrast, the surface of 5% PVA films appeared more compact in structure 190 
with very few pores.  191 
 192 
 10 
 193 
Figure 1. (a) Variation in storage modulus for 2 and 5% PVA blank films or films 194 
containing 3mg or 5 mg of NP. Data were plotted using TA Instrument Universal Analysis 195 
2000 software. (b) Variation in loss modulus for 2 and 5% PVA blank films or films 196 
containing 3mg or 5 mg of NP. Data were plotted using TA Instrument Universal Analysis 197 
2000 software. 198 
 199 
 200 
 11 
 201 
Figure 2. (a) Determination of storage modulus of 2% and 5% PVA films loaded with 3mg 202 
or 5 mg NPs. Data represent the mean +/-SD (N=3). (b) Determination of loss modulus of 203 
2% and 5% PVA films loaded with 3mg or 5 mg NPs. Data represent the mean +/-SD 204 
(N=3). 205 
 206 
 207 
Figure 3. In vitro cumulative release of 2% and 5% PVA films loaded with 3mg or 5 mg 208 
fluorescent NPs. Percentage of NPs released. Data represent mean+/-SD (N=3). 209 
 210 
 211 
 212 
 213 
 214 
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Table 1: Glass transition temperature determined using two different parameters: (A) 215 
storage modulus and (B) loss modulus. Data represents mean± SD (N=3).  216 
 217 
Glass Transition (°C) Blank Film 3mg NP loading 5mg NP loading 
2% PVA film 37.94 ±0.1 36.89±3.48 40.14±4.01 
5% PVA film 36.88±1.4 37.81±0.12 37.7±0.32 
 218 
Table 2:  Disintegration time for PVA films. 219 
PVA films 2% 
blank 
2% film + 
3mg NP 
2% film + 
5mg NP 
5% 
blank 
5% film + 
3mg NP 
5% film + 5mg 
NP 
Disintegration 
time 
3h 3h 3h Partially 
after 24 
h 
Partially 
after 24 h 
Partially after 
24 h 
 220 
Glass Transition (°C) Blank Film 3 mg NP loading 5 mg NP loading 
2% PVA film 39.61 ±2.76 53.25±2.86 54.10±7.63 
5% PVA film 37.57±0.28 40.05±2.09 42.07±2.21 
A)
 
B) 
 13 
 221 
Figure 4. Tensile strain of 2% and 5% PVA films loaded with 3mg or 5 mg of NPs. The 222 
onset point shown by the dark triangle, represents the moment the film started to tear. 223 
 224 
 225 
Table 3: Mechanical properties measured at room temperature for 2% and 5% PVA films 226 
loaded with 3mg or 5 mg NPs. Data represents mean± SD (N=3) 227 
  
Tensile 
strain 
(Extension) 
at Break 
(Standard) 
[%] 
Maximum 
Load 
[N] 
  
  
Modulus 
(Automatic 
Young's) 
[MPa] 
  
Tensile 
strain at 
Maximum 
stress 
[%] 
  
  
Tenacity at 
Maximum load 
[N/tex] 
2% blank 36.83±5.03 1.2±0.1 10.5±2.4 13.1±2.78 1.14±0.14 
2% film + 
3mg NP 41.03±5.36 0.86±0.15 7.36±0.77 16.23±2.5 1.16±0.2 
2% film + 
5mg NP 41.36±4.92 1±0.2 8.33±1.15 13.8±2.42 1.06±0.05 
5% film 
blank 28.76±1.5 7.23±0.49 128.2±18.37 5.24±0.87 7.68±0.72 
5% film + 
3mg NP 28.03±5.46 6.1±1.1 153.66±15.97 4.63±0.86 6.61±0.98 
5% film + 
5mg NP 25.76±2.03 7.16±0.3 133.03±18.94 5.76±2.1 6.52±1.14 
 228 
  229 
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 230 
Figure 5. SEM images of 2% and 5% PVA films containing 3mg or 5 mg of NP loading 231 
(2000x). 232 
 233 
 234 
4. Discussion  235 
Vaginal films have been developed for multiple purposes and present many advantages, but 236 
the films must be designed in a specific way to be acceptable, usable, and stable19. For 237 
vaginal films, it must possess certain characteristics so that it will not cause irritation or 238 
toxicity, must be flexible enough to be easily handled by the patient and more importantly, 239 
must allow the active compound to be released at a given time frame for a therapeutic 240 
effect. In this study, we determined the mechanical properties of PVA films containing NPs 241 
as previously developed4 . The film formulation using PVA and two different plasticisers 242 
(PEG 400 and glycerol) produce films that are smooth and slightly transparent. Different 243 
percentage of PVA produced different film thickness, which can play an important role in 244 
the thermodynamic properties of a film. In this study, we maintained the quantity of the 245 
plasticisers constant and changed the amount of PVA or NP loading and evaluated its 246 
effects on the mechanical properties of the films. The disintegration study presented in 247 
Table 2 showed that the 2% PVA film formulation broke down completely in 3 h. The 248 
amount of NPs loaded into the films appeared to have no impact on the rate of 249 
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disintegration but in contrast, the ratio of PVA/plasticiser used had an influence. Jun-Seo et 250 
al (2000), reported that the plasticising effect of PEG400 on PVA will make the film more 251 
flexible, and disintegrate more easily8. The film formulation containing 5% PVA was 252 
composed of a lower ratio of plasticiser/PVA. These films were thicker, can swell and 253 
partially break down after 24 h. A release study using fluorescent NP as presented in Fig 3 254 
correlated with the disintegration study. The 2% film formulation, which disintegrated 255 
faster, showed the highest concentration of NPs released after 4 h. This release increased 256 
slowly until 8 h and remained constant until 24 h. The higher NP released represent a very 257 
low percentage which can probably be explained by a rapid decay of the fluorophore used 258 
to fabricate the commercial PLGA NP during the film fabrication process and the release 259 
study. Films loaded with 5mg of NP exhibited higher release of NP compared to 2% and 260 
5% PVA films loaded with 3mg NP. Films formulated using 5% PVA exhibited a lower NP 261 
release profile which appears to be related to the slower disintegration rate in comparison to 262 
2% films. To further analyze the mechanical properties of the films, we used DMA to 263 
evaluate the storage modulus, which is a measurement of the elastic response of a material, 264 
and the loss modulus, which is the measurement of the viscous response of a material. 265 
Storage modulus and loss modulus are two parameters that we used to determine the 266 
transition temperature of the films. TA Instrument Universal Analysis 2000 software is 267 
used to integrate all curves in order to determine the glass transition derived from the 268 
storage and loss modulus. From looking at Fig 1A, in addition to plasticizers that increasing 269 
the mobility of polymer chains20, the presence of NPs in the film matrix affected the 270 
physical properties of the film possibly by reducing intermolecular forces21. This can 271 
decrease the storage modulus of the film and also affect the glass transition temperature as 272 
described by Ding et al.20. Less plasticizer gave a higher storage modulus as seen in with 273 
the 5% PVA film formulation compared to 2%. Based on the results, it appears that as we 274 
 16 
incorporate more PLGA NPs into the matrix of PVA, it will tend to make the films less 275 
stiff. We also evaluated the loss modulus, which measures the energy dissipated as heat in 276 
order to determine the glass transition temperature of the polymeric film. Glass transition 277 
temperature determined using the storage modulus present a transition state of blank films 278 
around 40°C. This transition state remained constant for 3 mg and 5 mg NP film loading in 279 
5% PVA film formulation. A small increase in glass transition temperature was observed 280 
for 2% PVA films loaded with 3 and 5 mg of NPs, which is around 50°C. This means that 281 
the 2 % PVA films loaded with NPs became more amorphous (semi-crystalline polymer) at 282 
a slightly higher temperature than 5% films containing the same loading of NPs. This might 283 
be due to the restriction of the NPs on the mobility of matrix segments of the film22. We 284 
also determined the glass transition temperature using the loss modulus.  All the transition 285 
temperatures using the loss modulus occurred around 38°C (Fig 2B). There was no 286 
significant difference between 2% and 5% PVA film formulations, either loaded with or 287 
without NPs. The amount of NPs loaded in the films did not have a significant impact on 288 
the glass transition temperature range. This shows that a transition takes place within the 289 
38-50°C temperature range. A wide temperature range was chosen (up to 80 ºC) to perform 290 
the thermal studies to mimic extreme conditions in which the film may potentially be 291 
subjected to e.g. countries with elevated ambient temperatures and inside a parked car 292 
where the temperature can rise up to 80 ºC23. Those conditions will affect the film stability 293 
and in some cases render them unusable.  When looking at the mechanical properties of the 294 
films, 2% films, which are very elastic due the ratio of plasticizer present, were very fragile 295 
and broke at a load of 1 N. On the other hand, 5% films were less elastic because of the 296 
lower ratio of plasticizer but more rigid, so they break at a load of around 7 N. Compared to 297 
2 % films, they supported a load higher than 6.5 N before breaking. The presence of NPs in 298 
the matrix of the films appeared to have no major effects on their elasticity. As revealed in 299 
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the SEM images (Fig 5), the blank 2% PVA films appeared to have a more porous structure 300 
while 2 mg and 5 mg NP loaded films did not display this property. The porous structures, 301 
as explained by Ping et al., are probably due to the shrinkage of the film due to rapid water 302 
evaporation while exposed to heat during the film formation24. They further explained that 303 
under heat, the molecular chains of PVA are inclined to rearrange to form crystalline 304 
regions. This may also explain why NP loaded films do not reveal obvious pores since the 305 
presence of the NPs in the polymer structure will interact with PVA molecules to prevent 306 
shrinkage. The porous morphology is less obvious in 5% films since the PVA ratio is 307 
higher but some small pores are visible. Vaginal Contraceptive Film® (VCF) (Apothecus 308 
Pharmaceutical) is a commercially available PVA based filmed containing glycerine as a 309 
plasticiser and nonoxynol-9 as a spermicide25. This film has been reported to have a 310 
relatively hard texture and having sharp edges26.  Those sharp edges and hard texture can 311 
potentially cause trauma to the female genital tract before the film is dissolved. In an effort 312 
to make our product softer and more pleasant for the user, we added PEG400 to supplement 313 
glycerol. The VCF film on the other hand exhibits faster dissolution (data not shown) 314 
compared to our formulation, which suggest that the viscoelasticity of PEG400 affects the 315 
film disintegration time.  316 
5. Conclusion 317 
The present study focused on the viscoelastic and mechanical behaviour of PVA films 318 
formulated along with NP for potential applications in vaginal drug delivery. The amount 319 
of PVA in the film formulation plays an important role in film disintegration and the 320 
release of the NPs. The presence of NPs in the film matrix did not significantly alter the 321 
film’s mechanical behaviour. On the other hand, presence of plasticisers such as PEG 400 322 
and glycerol enhanced the film’s flexibility, and played an important role in the rate of film 323 
 18 
disintegration and the rate of NP release from the films. Hence, film formulations can be 324 
customized for the controlled release of NPs with the desired viscoelastic and mechanical 325 
properties suitable for vaginal drug delivery.  326 
 327 
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